IRF4 and lymphoma: In addition, light chain restriction (kappa or lambda) and expression of markers such as BCL2 (B-cell lymphoma 2) or MUM1 (multiple myeloma oncogene 1, also known as IRF4) may further support the diagnosis of lymphoma. Recent consensus recommendations emphasize such multiparametric evaluation to standardize interpretation and minimize diagnostic pitfalls [16].